Literature DB >> 11535006

Vascular endothelial growth factor in chronic subdural haematomas.

T Shono1, T Inamura, T Morioka, K Matsumoto, S O Suzuki, K Ikezaki, T Iwaki, M Fukui.   

Abstract

OBJECTIVE: To elucidate molecular aspects of the mechanisms of expansion of chronic subdural haematomas (CSH), we examined the expression of two representative angiogenic factors, vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in CSH.
METHODS: We quantified VEGF and bFGF in haematoma fluid and serum of 20 patients with CSH using an enzyme-linked immunosorbent assay. Mean concentrations of VEGF in the haematoma fluid (10277 pg/ml) and in serum, (355 pg/ml) were much greater than those of bFGF (haematoma, 3.04 pg/ml; serum, 4.74 pg/ml). Surgical specimens, including dura and the outer membrane of the CSH were analysed by in situ hybridisation to detect VEGF mRNA. Macrophages and vascular endothelial cells in the outer membrane over expressed VEGF mRNA.
CONCLUSIONS: Enhanced production of VEGF by macrophages and vascular endothelial cells in the outer membrane is thought to be pathogenetically important in CSH. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11535006     DOI: 10.1054/jocn.2000.0951

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  22 in total

1.  Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study.

Authors:  Milo Stanisic; Ansgar Oddne Aasen; Are Hugo Pripp; Karl-Fredrik Lindegaard; Jon Ramm-Pettersen; Staale Petter Lyngstadaas; Jugoslav Ivanovic; Ane Konglund; Eivind Ilstad; Tiril Sandell; Omar Ellingsen; Terje Sæhle
Journal:  Inflamm Res       Date:  2012-04-19       Impact factor: 4.575

2.  A case of complete clearance of chronic subdural hematoma accompanied by recurrent glioblastoma multiforme after administration of bevacizumab.

Authors:  Keiko Suzuki; Tomoyuki Kawataki; Kazuya Kanemaru; Kentaro Mitsuka; Masakazu Ogiwara; Hiroki Sato; Hiroyuki Kinouchi
Journal:  Neurosurg Rev       Date:  2016-02-26       Impact factor: 3.042

3.  Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural Hematoma.

Authors:  Cong Hua; Gang Zhao; Yan Feng; Hongyan Yuan; Hongmei Song; Li Bie
Journal:  J Neurotrauma       Date:  2015-08-06       Impact factor: 5.269

Review 4.  Membranectomy in Chronic Subdural Hematoma: Meta-Analysis.

Authors:  Ronald Sahyouni; Hossein Mahboubi; Peter Tran; John S Roufail; Jefferson W Chen
Journal:  World Neurosurg       Date:  2017-05-13       Impact factor: 2.104

Review 5.  Chronic Subdural Hematoma: A Perspective on Subdural Membranes and Dementia.

Authors:  Ronald Sahyouni; Khodayar Goshtasbi; Amin Mahmoodi; Diem Kieu Tran; Jefferson W Chen
Journal:  World Neurosurg       Date:  2017-09-19       Impact factor: 2.104

6.  Contrast enhancement of chronic subdural hematomas after embolization of the middle meningeal artery.

Authors:  Pouya Entezami; Alan Boulos; Alexandra Paul; Emad Nourollahzadeh; John Dalfino
Journal:  Interv Neuroradiol       Date:  2019-04-24       Impact factor: 1.610

Review 7.  The pathophysiology of chronic subdural hematoma revisited: emphasis on aging processes as key factor.

Authors:  Ralf Weigel; Lothar Schilling; Joachim K Krauss
Journal:  Geroscience       Date:  2022-04-23       Impact factor: 7.581

8.  Middle meningeal artery embolization for chronic subdural hematoma: Endovascular technique and radiographic findings.

Authors:  Thomas W Link; Benjamin I Rapoport; Stephanie M Paine; Hooman Kamel; Jared Knopman
Journal:  Interv Neuroradiol       Date:  2018-05-02       Impact factor: 1.610

9.  Hemorrhagic lumbar facet cysts accompanying a spinal subdural hematoma at the same level.

Authors:  Osamu Ikeda; Norihiko Minami; Masashi Yamazaki; Masao Koda; Tatsuo Morinaga
Journal:  J Spinal Cord Med       Date:  2014-06-29       Impact factor: 1.985

10.  Impact of inflammatory cell ratio, biomarkers, activated partial thromboplastin time and prothrombin time on chronic subdural haematoma severity and outcome.

Authors:  Olufemi Emmanuel Idowu; Stevens Olaide Oyeleke; Julius Mautin Vitowanu
Journal:  Eur J Trauma Emerg Surg       Date:  2021-04-11       Impact factor: 3.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.